Michael Ong
Impact in
Papers in
-
- Prostate Cancer Treatment and Research 28
- Oncology 41
- Cancer Immunotherapy and Biomarkers 10
- Cancer Treatment and Pharmacology 9
- Colorectal Cancer Treatments and Studies 6
- Co-authors
- Srikala S. Sridhar (10 shared papers)Peter H. O’Donnell (6 shared papers)Terence W. Friedlander (5 shared papers)Jingsong Zhang (5 shared papers)Nicholas J. Vogelzang (3 shared papers)Joyce Antal (3 shared papers)Sandy Srinivas (3 shared papers)Christophe Massard (4 shared papers)
- Journals
- Journal of Clinical Oncology (34 papers)Journal of the American Academy of Dermatology (3 papers)Supportive Care in Cancer (3 papers)The Journal of Urology (2 papers)Cancers (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Michael Ong
83 papers receiving 1.8k citations
Michael Ong's Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 879
- Surgery 512
- Pulmonary and Respiratory Medicine 348
- Immunology 209
- Cancer Research 129
Countries citing papers authored by Michael Ong
This map shows the geographic impact of Michael Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ong more than expected).
Fields of papers citing papers by Michael Ong
This network shows the impact of papers produced by Michael Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ong. The network helps show where Michael Ong may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Ong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma Hit paper breakdown → | 2017 | 665 |
| 2 | 2015 | 104 | |
| 3 | 2006 | 98 | |
| 4 | 2013 | 72 | |
| 5 | 2016 | 72 | |
| 6 | 2013 | 62 | |
| 7 | 2020 | 61 | |
| 8 | 2017 | 58 | |
| 9 | 2020 | 40 | |
| 10 | 2016 | 38 | |
| 11 | 2012 | 38 | |
| 12 | 2017 | 32 | |
| 13 | 2012 | 31 | |
| 14 | 2022 | 31 | |
| 15 | 2015 | 29 | |
| 16 | 2014 | 24 | |
| 17 | 2014 | 23 | |
| 18 | 2020 | 15 | |
| 19 | 2018 | 14 | |
| 20 | 2020 | 13 |
About Michael Ong
Michael Ong is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 91 papers that have together received 1.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (28 papers), Cancer Genomics and Diagnostics (14 papers), Bladder and Urothelial Cancer Treatments (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Treatment and Pharmacology (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer, Lipids, and Metabolism (6 papers). The work is most often cited by research in Oncology (879 citations), Surgery (512 citations), Pulmonary and Respiratory Medicine (348 citations), Immunology (209 citations) and Cancer Research (129 citations). Michael Ong has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Srikala S. Sridhar, Peter H. O’Donnell, Terence W. Friedlander, Jingsong Zhang, Nicholas J. Vogelzang, Joyce Antal, Sandy Srinivas, Christophe Massard, Noah M. Hahn and Jae‐Lyun Lee. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American Academy of Dermatology, Supportive Care in Cancer, The Journal of Urology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.